4th Biennial World Summit of Brain Tumour Patient Advocates
9.-12. Oktober 2019
Bethesda, MD, USA
Teilnehmer: Dr. Irina Odnoletkova, MBA, VP Health Technology Assessment
Festival of Biologics
15.-17. Oktober 2019
Basel, Schweiz
Teilnehmer:
Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering
Dr. Oliver Hill, VP Drug Discovery/Lead Optimization
Präsentation am 16. Oktober um 12:05 Uhr:
"HERA-CD40L: A unique hexavalent CD40 agonist for cancer immunotherapy"
ISPOR Europe 2019
2.-6. November 2019
Kopenhagen, Dänemark
Teilnehmer: Dr. Irina Odnoletkova, MBA, VP Health Technology Assessment
Poster-Präsentation am 4. November, 15:30-19:00 Uhr (Poster Author Discussion Hour: 18:00-19:00 Uhr):
"Therapeutic Benefit of Orphan Drugs in Oncology: Evidence at the Point of European Marketing Authorisation"
BIO-Europe 2019
11.-13. November 2019
Hamburg
Teilnehmer:
Dr. Jürgen Gamer, VP Business Development
Dr. Niclas Kneisel, Alliance Manager
11th Annual PEGS Europe
18.-22. November 2019
Lissabon, Portugal
Teilnehmer:
Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering
Dr. Oliver Hill, VP Drug Discovery/Lead Optimization
Präsentation von Dr. Hill am 22. November um 14:35 Uhr:
"HERA-GITRL: A Unique Hexavalent GITR Agonist for Cancer Immunotherapy"
SNO 2019 Annual Meeting
22.-24. November 2019
Phoenix, AZ, USA
Teilnehmer: Dr. Jürgen Gamer, VP Business Development
8th Annual PREDiCT: Tumour Models London Summit
4.-6. Dezember 2019
London, UK
Teilnehmer: Dr. Mauricio Redondo-Müller, Director Preclinical Development
19th Annual PepTalk
20.-24. Januar 2020
San Diego, CA, USA
Teilnehmer: Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering
AACR Annual Meeting 2020
24.-29. April 2020
San Diego, CA, USA
Teilnehmer:
Dr. Christian Gieffers, VP Protein Chemistry
Dr. Christian Merz, Head of Cellular Analytics
Dr. Meinolf Thiemann, Director Protein Analytics